Pharmabiz5h
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients
Vattikuti Foundation- AIIMS join hands to offer succour to Parkinson's, essential tremors patients: Our Bureau, Mumbai Friday ...
Pharmabiz7h
Rusan Pharma’s chairman Dr Navin Saxena conferred with Russia’s prestigious ‘Order of Friendship’ and ‘Academic Honour’
Rusan Pharma Ltd., is a global leader in pharmaceutical innovation, proudly announces that its chairman, Dr. Navin Saxena, ...
Pharmabiz7h
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma
Antengene’s Xpovio approved for reimbursement in Taiwan to treat adult patients with relapsed/refractory multiple myeloma: Shanghai Friday, February 14, 2025, 16:00 Hrs [IST] An ...
Pharmabiz7h
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market
Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market: Our Bureau, Mumbai Friday, February 14, ...
Pharmabiz5h
Implantica receives positive feedback from US FDA for RefluxStop PMA Module 2 submission
Implantica receives positive feedback from US FDA for RefluxStop PMA Module 2 submission: Vaduz, Liechtenstein Friday, February 14, 2025, 18:00 Hrs [IST] Implantica AG (publ.), a ...
Pharmabiz6h
Tivic Health acquires exclusive global rights to TLR5 agonist Entolimod from Statera Biopharma to treat acute radiation syndrome
Fremont, California Friday, February 14, 2025, 17:00 Hrs [IST] ...
Pharmabiz11h
Sanofi announces update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
Sanofi announces update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study: Paris Friday, February 14, 2025, 12:00 Hrs [IST] A scheduled review of the E.mbrace p ...
Pharmabiz8h
Santhera announces agreement with German GKV-SV on reimbursement for Agamree to treat Duchenne muscular dystrophy
Pratteln, Switzerland Friday, February 14, 2025, 15:00 Hrs [IST] ...
Pharmabiz14h
US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy
US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...
Pharmabiz10h
Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy
Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...
Pharmabiz12h
Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma
Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma: New York Friday, February 14, 2025, 11:00 Hrs [IST] Pfizer ...
Pharmabiz11h
Glenmark Pharma introduces generic Xalatan ophthalmic solution, 0.005% in US
Glenmark Pharma introduces generic Xalatan ophthalmic solution, 0.005% in US: Our Bureau, Mumbai Friday, February 14, 2025, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc., USA (Gle ...